Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleClinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.AuthorsHelweg-Larsen, Jannik; Benfield, Thomas; Atzori, Chiara; Miller, Robert F.AbstractObjectives: First-line therapy for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim/sulfamethoxazole. Few data exist to guide the choice of second-line therapy for patients failing or developing toxicity to first-line therapy.SubjectsTHERAPEUTICS research; PNEUMOCYSTIS carinii pneumonia treatment; TRIMETHOPRIM; SULFAMETHOXAZOLE; MEDICAL care; TOXICOLOGY; THERAPEUTICSPublicationJournal of Antimicrobial Chemotherapy (JAC), 2009, Vol 64, Issue 6, p1282ISSN0305-7453Publication typeArticleDOI10.1093/jac/dkp372